Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Gerber

Showing results (141-150 of 289) with videos related to

Pageof 29
Sort By:
Clinical Lung Cancer|September 7, 2021
CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung CancerDirk De Ruysscher, Suresh Ramalingam, James Urbanic, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 4, 2020
Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort studyTimothy J Brown, Neil Keshvani, Arjun Gupta, et al.
Cancer|November 14, 2024
Implantable cardioverter defibrillators in people dying with cancer: A SEER-Medicare analysis of ICD prevalence and association with aggressive end-of-life careMegan A Mullins, Tianci Wang, Kathryn Shahan, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2012
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesotheliomaJonathan E Dowell, Frank R Dunphy, Robert N Taub, et al.
Frontiers in Oncology|April 29, 2021
Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung CancerShetal A Patel, David E Gerber, Allison Deal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2019
Conceptual Model for Accrual to Cancer Clinical TrialsSimon J Craddock Lee, Caitlin C Murphy, Ann M Geiger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2019
DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint InhibitorsJin-Sung Chung, Vijay Ramani, Masato Kobayashi, et al.
JTO Clinical and Research Reports|October 16, 2023
Initial Steps in Creating a Patient-Centric Addendum to Clinical Trial Informed Consent FormsBellinda L King-Kallimanis, Andrea Ferris, Lisa Dropkin, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 11, 2026
Association of Vaping-Related Events with Relative Harm Perceptions of E-CigarettesAlexander Wu, Sumin Son, Matthew Lee, et al.
Clinical Lung Cancer|October 17, 2022
Antibiotic Prescriptions in Lung Cancer and Melanoma Populations: Differences With Potential Clinical Implications in the Immunotherapy EraAmrit S Gonugunta, Mitchell S Von Itzstein, David Hsiehchen, et al.
Pageof 29

Showing results (141-150 of 289) with videos related to

Sort By:
Pageof 29
Clinical Lung Cancer|September 7, 2021
CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung CancerDirk De Ruysscher, Suresh Ramalingam, James Urbanic, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 4, 2020
Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort studyTimothy J Brown, Neil Keshvani, Arjun Gupta, et al.
Cancer|November 14, 2024
Implantable cardioverter defibrillators in people dying with cancer: A SEER-Medicare analysis of ICD prevalence and association with aggressive end-of-life careMegan A Mullins, Tianci Wang, Kathryn Shahan, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2012
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesotheliomaJonathan E Dowell, Frank R Dunphy, Robert N Taub, et al.
Frontiers in Oncology|April 29, 2021
Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung CancerShetal A Patel, David E Gerber, Allison Deal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2019
Conceptual Model for Accrual to Cancer Clinical TrialsSimon J Craddock Lee, Caitlin C Murphy, Ann M Geiger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2019
DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint InhibitorsJin-Sung Chung, Vijay Ramani, Masato Kobayashi, et al.
JTO Clinical and Research Reports|October 16, 2023
Initial Steps in Creating a Patient-Centric Addendum to Clinical Trial Informed Consent FormsBellinda L King-Kallimanis, Andrea Ferris, Lisa Dropkin, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 11, 2026
Association of Vaping-Related Events with Relative Harm Perceptions of E-CigarettesAlexander Wu, Sumin Son, Matthew Lee, et al.
Clinical Lung Cancer|October 17, 2022
Antibiotic Prescriptions in Lung Cancer and Melanoma Populations: Differences With Potential Clinical Implications in the Immunotherapy EraAmrit S Gonugunta, Mitchell S Von Itzstein, David Hsiehchen, et al.
Pageof 29